SEARCH

SEARCH BY CITATION

References

  • 1
    Based on OPTN data as of January 26, 2003 http://www. OPTN.org
  • 2
    Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL. Morbidity and mortality after living kidney donation, 1999–2001: survey of United States transplant centers. Am J Transplant 2003; 3: 830834.
  • 3
    National Highway Traffic Safety Administration Fatality Analysis Reporting System (FARS). Web-based encyclopedia. http://www. fars.nhtsa.dot.gov
  • 4
    Ratner LE, Ciseck LJ, Moore RG et al. Laparoscopic live donor nephrectomy. Transplantation 1995; 60: 10471049.
  • 5
    Ratner LE, Montgomery RA, Kavoussi LR. Laparoscopic live donor nephrectomy: a review of the first 5 years. Urol Clin North Am 2001; 28: 709719.
  • 6
    Wolf JS, Jr, Merion RM, Leichtman AB et al. Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation 2001; 72: 284290.
  • 7
    Odland MD, Ney AL, Jacobs DM et al. Initial experience with laparoscopic live donor nephrectomy. Surgery 1999; 126: 603606.
  • 8
    Weiss MJ, Sinkov V, Fox-Talbot K et al. Worldwide adoption and dissemination of laparoscopic live donor nephrectomy: relevance of economic and surgical training factors. In preparation.
  • 9
    Toma H, Tanabe K, Tokumoto T. Long-term outcome of ABO-incompatible renal transplantation. Urol Clin North Am 2001; 28: 76697780.
  • 10
    Montgomery RA, Zachary AA, Racusen LE et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70: 887895.